Aberrant alpha 1-->2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors.
about
ABH and Lewis histo-blood group antigens in cancer.Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression.Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification.Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinantsFucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.Molecular cloning and expression of a third type of rabbit GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase.The chemical neurobiology of carbohydratesFucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review.Detection of a potential receptor for the H-blood-group antigen on rat colon-carcinoma cells and normal tissues.Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues.Peptide mimotopes of carbohydrate antigens.α(1,2)fucosylation in human colorectal carcinoma.Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers.alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis.Drug resistance related to aberrant glycosylation in colorectal cancer.alpha1,2Fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells.Enzymatic basis for the accumulation of Lewis(b) antigen in uterine endometrial cancer.
P2860
Q34215529-D2E84852-653D-4DC6-B973-D0EA3DFD1051Q34252468-EA5DDE86-9F54-4DEA-AFB1-B0622FB33BF8Q34351520-E549F6B9-23CC-458F-8EBB-1740D176263DQ36014843-9F7698EA-CC35-4F20-A7F9-54903ACA9DA3Q36050468-CD4561CB-DE45-422E-A2C7-6D418AA4C49EQ36802955-3FFD768A-8FF8-4142-855F-87750789C0D5Q37152815-2C8446BC-7E37-4FB0-920F-7CA80E639C4DQ38211812-B5CBA76B-714D-4552-AA4B-1F45A77C7375Q38338712-977D3E9B-B7B5-4F3D-AE5A-819132F83DB3Q40231601-A498F5C3-A7E9-4AB1-8D5F-4CA5D24DBD69Q41710754-965F0421-1E58-44E8-BBE0-5BF4586D041FQ42323734-7DE4A421-FDA8-41B8-8306-A8064E4D10A1Q44205217-563E9517-243C-4CCF-93DA-B78AAFE03158Q45146173-BE6AA090-5450-430F-8811-F38C7254F878Q49185043-05DABA7A-1C89-4E1A-9842-497794464E6FQ54055464-91C7B216-96EC-4887-BC12-0470A7B81144Q54954524-BABE11C0-9EE4-4101-BF8F-3D3201A148A2
P2860
Aberrant alpha 1-->2fucosyltransferases found in human colorectal carcinoma involved in the accumulation of Leb and Y antigens in colorectal tumors.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@en
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@nl
type
label
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@en
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@nl
prefLabel
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@en
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@nl
P2093
P2860
P1476
Aberrant alpha 1-->2fucosyltra ...... antigens in colorectal tumors.
@en
P2093
J Nakamura
M Akamatsu
T Tachikawa
Y Nagamachi
P2860
P304
P356
10.1111/J.1349-7006.1993.TB00190.X
P577
1993-09-01T00:00:00Z